Literature DB >> 31512355

The high prevalence and impact of rheumatic heart disease in pregnancy in First Nations populations in a high-income setting: a prospective cohort study.

E A Sullivan1,2, G Vaughan2, Z Li2, M J Peek3, J R Carapetis4,5, W Walsh6,7, J Frawley2, Mgw Rémond2, B Remenyi8, L Jackson Pulver9, S Kruske10,11, S Belton8, C McLintock12.   

Abstract

OBJECTIVE: To describe the epidemiology of rheumatic heart disease (RHD) in pregnancy in Australia and New Zealand (A&NZ).
DESIGN: Prospective population-based study.
SETTING: Hospital-based maternity units throughout A&NZ. POPULATION: Pregnant women with RHD with a birth outcome of ≥20 weeks of gestation between January 2013 and December 2014.
METHODS: We identified eligible women using the Australasian Maternity Outcomes Surveillance System (AMOSS). De-identified antenatal, perinatal and postnatal data were collected and analysed. MAIN OUTCOME MEASURES: Prevalence of RHD in pregnancy. Perinatal morbidity and mortality.
RESULTS: There were 311 pregnancies associated with women with RHD (4.3/10 000 women giving birth, 95% CI 3.9-4.8). In Australia, 78% were Aboriginal or Torres Strait Islander (60.4/10 000, 95% CI 50.7-70.0), while in New Zealand 90% were Māori or Pasifika (27.2/10 000, 95% CI 22.0-32.3). One woman (0.3%) died and one in ten was admitted to coronary or intensive care units postpartum. There were 314 births with seven stillbirths (22.3/1000 births) and two neonatal deaths (6.5/1000 births). Sixty-six (21%) live-born babies were preterm and one in three was admitted to neonatal intensive care or special care units.
CONCLUSION: Rheumatic heart disease in pregnancy persists in disadvantaged First Nations populations in A&NZ. It is associated with significant cardiac and perinatal morbidity. Preconception planning and counselling and RHD screening in at-risk pregnant women are essential for good maternal and baby outcomes. TWEETABLE ABSTRACT: Rheumatic heart disease in pregnancy persists in First Nations people in Australia and New Zealand and is associated with major cardiac and perinatal morbidity.
© 2019 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  First Nations; maternal health; perinatal outcomes; rheumatic heart disease; stillbirth

Mesh:

Year:  2019        PMID: 31512355     DOI: 10.1111/1471-0528.15938

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  5 in total

1.  Caring for Pregnant Women with Rheumatic Heart Disease: A Qualitative Study of Health Service Provider Perspectives.

Authors:  Geraldine Vaughan; Angela Dawson; Michael Peek; Jonathan Carapetis; Vicki Wade; Elizabeth Sullivan
Journal:  Glob Heart       Date:  2021-12-22

Review 2.  Rheumatic Heart Disease in Pregnancy: New Strategies for an Old Disease?

Authors:  Geraldine Vaughan; Angela Dawson; Michael Peek; Karen Sliwa; Jonathan Carapetis; Vicki Wade; Elizabeth Sullivan
Journal:  Glob Heart       Date:  2021-12-20

3.  Tamil Nadu Pregnancy and Heart Disease Registry (TNPHDR): design and methodology.

Authors:  Justin Paul Gnanaraj; S Anne Princy; Karen Sliwa-Hahnle; Sowmya Sathyendra; Nambirajan Jeyabalan; Ragothaman Sethumadhavan; Selvarani G; N Sumathi; Vinotha S; Pachaiappan P; Vimali Murali; Shanthirani B; Gomathi T; Muthuprabha P; Panniyammakal Jeemon; E Elavarasi; Rajarajeshwari R; Vijaya S; Kanmani K
Journal:  BMC Pregnancy Childbirth       Date:  2022-01-29       Impact factor: 3.007

4.  Non-linear Relationship of Maternal Age With Risk of Spontaneous Abortion: A Case-Control Study in the China Birth Cohort.

Authors:  Man Zhang; Bo-Yi Yang; Yongqing Sun; Zhengmin Qian; Pamela K Xaverius; Hannah E Aaron; Xiaoting Zhao; Zheng Zhang; Ruixia Liu; Guang-Hui Dong; Chenghong Yin; Wentao Yue
Journal:  Front Public Health       Date:  2022-07-14

5.  Characteristics shifting of heart disease in pregnancy: A report from low middle-income country.

Authors:  Cyntia Puspa Pitaloka; Absa Secka; Ernawati Ernawati; Agus Sulistyono; Hermanto Tri Juwono; Erry Gumilar Dachlan; Aditiawarman Aditiawarman
Journal:  J Public Health Res       Date:  2021-07-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.